These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8457637)

  • 1. Fibrin degradation products in growth stimulatory extracts of pathological lesions.
    Thompson WD; Smith EB; Stirk CM; Wang J
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):113-5. PubMed ID: 8457637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products.
    Thompson WD; Smith EB; Stirk CM; Kochhar A
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):489-93. PubMed ID: 1723306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic activity of fibrin degradation products is located in fibrin fragment E.
    Thompson WD; Smith EB; Stirk CM; Marshall FI; Stout AJ; Kocchar A
    J Pathol; 1992 Sep; 168(1):47-53. PubMed ID: 1280677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The control of fibrogenesis: stimulation and suppression of collagen synthesis in the chick chorioallantoic membrane with fibrin degradation products, wound extracts and proteases.
    Thompson WD; Evans AT; Campbell R
    J Pathol; 1986 Mar; 148(3):207-15. PubMed ID: 3009765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors relevant to stimulatory activity of fibrin degradation products in vivo.
    Thompson WD; Smith EB; Stirk CM; Stout AJ; Kochhar A
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):517-20. PubMed ID: 1723307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of growth-stimulating fibrin degradation products containing fragment E in human atherosclerotic plaques.
    Stirk CM; Kochhar A; Smith EB; Thompson WD
    Atherosclerosis; 1993 Nov; 103(2):159-69. PubMed ID: 7507326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.
    Naito M; Stirk CM; Smith EB; Thompson WD
    Thromb Res; 2000 Apr; 98(2):165-74. PubMed ID: 10713318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
    Isogai N; Yamagishi T; Kaku M; Matsumoto K; Yamamoto Y; Kuroso K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
    Rinsho Byori; 1991 Jul; 39(7):753-7. PubMed ID: 1920869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.
    Smith EB
    Clin Haematol; 1986 May; 15(2):355-70. PubMed ID: 3524931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin degradation and angiogenesis: quantitative analysis of the angiogenic response in the chick chorioallantoic membrane.
    Thompson WD; Campbell R; Evans T
    J Pathol; 1985 Jan; 145(1):27-37. PubMed ID: 2578560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN
    Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis and angiogenesis in wound healing.
    Thompson WD; Harvey JA; Kazmi MA; Stout AJ
    J Pathol; 1991 Dec; 165(4):311-8. PubMed ID: 1723752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma.
    Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W
    Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment E derived from both fibrin and fibrinogen stimulates interleukin-6 production in rat peritoneal macrophages.
    Lee ME; Rhee KJ; Nham SU
    Mol Cells; 1999 Feb; 9(1):7-13. PubMed ID: 10102564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A specific marker of thrombolysis: DDE complex].
    Soria J; Soria C; Mirshahi M; Mirshahi M; Boucheix C; Pujade E; Perrot JY; Samama M; Bernadou A; Caen JP
    C R Acad Sci III; 1987; 304(11):307-11. PubMed ID: 3103876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
    Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
    Raut S; Gaffney PJ
    Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.